Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of $575.53 billion as of July 26, 2024. Its market cap has increased by 63.12% in one year.

Market Cap

575.53B

Enterprise Value

578.09B

1-Year Change

63.12%

Ranking

#15

Market Cap Chart

Since December 31, 2002, Novo Nordisk's market cap has increased from $9.98B to $575.53B, an increase of 5,667.35%. That is a compound annual growth rate of 20.67%.

Market Cap History

Date	Market Cap	% Change
Jul 25, 2024	576.65B	22.24%
Dec 29, 2023	471.73B	54.12%
Dec 30, 2022	306.08B	19.24%
Dec 31, 2021	256.69B	55.86%
Dec 31, 2020	164.70B	16.14%
Dec 31, 2019	141.81B	23.12%
Dec 31, 2018	115.18B	-15.84%
Dec 29, 2017	136.86B	46.79%
Dec 30, 2016	93.24B	-38.18%
Dec 31, 2015	150.82B	29.59%
Dec 31, 2014	116.38B	12.48%
Dec 31, 2013	103.47B	9.30%
Dec 31, 2012	94.66B	36.88%
Dec 30, 2011	69.16B	-0.91%
Dec 31, 2010	69.79B	72.41%
Dec 31, 2009	40.48B	26.82%
Dec 31, 2008	31.92B	-22.43%
Dec 31, 2007	41.15B	52.03%
Dec 29, 2006	27.07B	44.82%
Dec 30, 2005	18.69B	1.87%
Dec 31, 2004	18.35B	29.73%
Dec 31, 2003	14.14B	41.73%
Dec 31, 2002	9.98B	-

View and export this data all the way back to 2002. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	819.00B
UnitedHealth Group	514.20B
Johnson & Johnson	374.91B
Merck & Co.	319.01B
AbbVie	311.13B
AstraZeneca	246.40B
Thermo Fisher	217.56B
Novartis AG	214.65B

Market Cap Rankings